<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8100437</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6047</journal-id>
<journal-id journal-id-type="nlm-ta">Neurobiol Aging</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurobiol. Aging</journal-id>
<journal-title-group>
<journal-title>Neurobiology of aging</journal-title>
</journal-title-group>
<issn pub-type="ppub">0197-4580</issn>
<issn pub-type="epub">1558-1497</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28391068</article-id>
<article-id pub-id-type="pmc">5498112</article-id>
<article-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.03.018</article-id>
<article-id pub-id-type="manuscript">NIHMS871530</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Abnormal Trajectories in Cerebellum and Brainstem Volumes in Carriers of the Fragile X Premutation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Jun Yi</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hessl</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hagerman</surname>
<given-names>Randi J.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Simon</surname>
<given-names>Tony J.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tassone</surname>
<given-names>Flora</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferrer</surname>
<given-names>Emilio</given-names>
</name>
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rivera</surname>
<given-names>Susan M.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Center for Mind and Brain, University of California-Davis, Davis, CA, USA</aff>
<aff id="A2"><label>b</label>Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California-Davis Medical Center, Sacramento, CA, USA</aff>
<aff id="A3"><label>c</label>Department of Psychiatry and Behavioral Sciences, University of California-Davis, School of Medicine, Sacramento, CA, USA</aff>
<aff id="A4"><label>d</label>Department of Pediatrics, University of California-Davis, School of Medicine, Sacramento, CA, USA</aff>
<aff id="A5"><label>e</label>Department of Biochemistry and Molecular Medicine, University of California-Davis, School of Medicine, Sacramento, CA, USA</aff>
<aff id="A6"><label>f</label>Department of Psychology, University of California-Davis, Davis, CA, USA</aff>
<author-notes>
<corresp id="FN1">Correspondence: Dr. Jun Yi Wang, Center for Mind and Brain, 267 Cousteau Place, Davis, CA 95618 <italic>Phone</italic>: 530.747.3802, Fax: 530.297.4603, <email>jyiwang@ucdavis.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>3</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>7</month>
<year>2018</year>
</pub-date>
<volume>55</volume>
<fpage>11</fpage>
<lpage>19</lpage>
<!--elocation-id from pubmed: 10.1016/j.neurobiolaging.2017.03.018-->
<abstract>
<p id="P2">Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder typically affecting male premutation carriers with 55–200 CGG repeat expansions in the <italic>FMR1</italic> gene after age 50. The aim of this study was to examine whether cerebellar and brainstem changes emerge during development or aging in late life. We retrospectively analyzed MRI scans from 322 males (age 8–81 years). Volume changes in the cerebellum and brainstem were contrasted with those in the ventricles and whole brain. Compared to the controls, premutation carriers without FXTAS showed significantly accelerated volume decrease in the cerebellum and whole brain, flatter inverted U-shaped trajectory of the brainstem, and larger ventricles. Compared to both older controls and premutation carriers without FXTAS, carriers with FXTAS exhibited significant volume decrease in the cerebellum and whole brain and accelerated volume decrease in the brainstem. We therefore conclude that cerebellar and brainstem volumes were likely affected during both development and progression of neurodegeneration in premutation carriers, suggesting that interventions may need to start early in adulthood to be most effective.</p>
</abstract>
<kwd-group>
<kwd>fragile X</kwd>
<kwd>FXTAS</kwd>
<kwd>fragile X premutation</kwd>
<kwd>
<italic>FMR1</italic>
</kwd>
<kwd>MRI</kwd>
<kwd>neurodegenerative disorder</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>